6760
L. M. T. Frija et al. / Tetrahedron Letters 46 (2005) 6757–6760
´
18. Gomez-Zavaglia, A.; Reva, I. D.; Frija, L.; Cristiano, M.
methodology to this class of compounds. Further inves-
tigations are in progress.
L.; Fausto, R. J. Photochem. Photobiol. A: Chem.,
submitted for publication.
19. 1-Phenyl-4-(prop-2-enyl) tetrazol-5-one 4a from 1-phenyl-
5-(prop-2-enyloxy) tetrazole 3a (1.00 g; 4.90 mmol) heated
neat at 150 °C for 3 h. 1H NMR (CDCl3): d 4.65 (2H, d, J
5.7), 5.30–5.50 (2H, m), 5.90–6.10 (1H, m), 7.40–7.60 (3H,
m), 8.00 (2H, d, J 6.86); mmax.: 1729 (C@O), 1598, 1504,
1388 and 757 cmꢀ1; MS (EI), m/z 202 [M]+. Found: C,
59.8; H, 5.2; N, 28.1%. Calcd for C10H10N4O: C, 59.4; H,
5.0; N, 27.7%.
Acknowledgements
The authors are grateful to FCT, Portugal and FEDER
for financial support (POCTI/P/FCB/33580/00 and
SFRH/BD/17945/2004 (LMTF)).
20. 4-(1-Methylprop-2-enyl)-tetrazol-5-one 4b from 1-phenyl-
5-[(E)-but-2-enyloxy]tetrazole 3b, 150 °C, 2 h. 1H NMR
(CDCl3): d 1.65 (3H, d, J 5.7), 4.90–5.10 (1H, m), 5.22–5.4
(2H, m), 6.0–6.2 (1H, m), 7.30–7.55 (3H, m), 7.95 (2H, d, J
References and notes
8.6); mmax.: 1729 (C@O), 1599, 1504, 1382 and 757 cmꢀ1
;
1. Rovnyak, G. C.; Atwal, K. S.; Hedberg, A.; Kimball, S.
D.; Moreland, S.; Gougoutas, J. Z.; OÕReilly, B. C.;
Schwartz, J.; Malley, M. F. J. Med. Chem. 1992, 35,
3254.
2. Atwal, K. S. et al. J. Med. Chem. 1990, 33, 1510–1515.
3. Matsuda, T.; Hirao, I. Nippon Kagaku Zasshi 1965, 86,
1195–1197.
4. Sadanandam, Y. S.; Shetty, M. M.; Diwan, P. V. Eur. J.
Med. Chem. 1992, 27, 87–92.
5. Kato, T. Jpn. Kokai Tokkyo Koho JP 1984, 59, 190, 974
[Chem. Abstr. 102 (1985) 132067].
MS (EI), m/z 216 [M]+. Found: C, 61.0; H, 5.6; N, 26.1%.
Calcd for C11H12N4O: C, 61.1; H, 5.6; N, 25.9%.
21. 1-Phenyl-4-(1-phenylprop-2-enyl)-tetrazol-5-one 4c from
1-phenyl-5-[(E)-3-phenylprop-2-enyloxy] tetrazole 3c,
100 °C, 2 h. 1H NMR (CDCl3): d 5.28–5.52 (2H, m),
6.00 (1H, d, J 5.7), 6.36–6.55 (1H, m), 7.30–7.50 (7H, m),
7.95 (2H, d, J 8.6); mmax.: 1729 (C@O), 1598, 1504, 1382
and 756 cmꢀ1; MS (EI), m/z 278 [M]+. Found: C, 68.8; H,
5.0; N, 20.4%. Calcd for C16H14N4O: C, 69.1; H, 5.1; N,
20.1%.
6. Lagu, B. et al. Bioorg. Med. Chem. Lett. 2000, 10, 175–
178.
7. Steele, T. G.; Coburn, C. A.; Patane, M. A.; Bock, M. G.
Tetrahedron Lett. 1998, 39, 9315–9318.
8. Kappe, C. O. Tetrahedron (review) 1993, 49, 6937–6963.
9. Hu, E. H.; Sidler, D. R.; Dolling, U.-H. J. Org. Chem.
1998, 63, 3454.
10. Bugalho, S. C. S.; Serra, A. C.; Lapinskii, L.; Cristiano,
M. L. S.; Frija, L. M. T.; Fausto, R. Vib. Spectrosc. 2002,
3541–3547.
11. Cristiano, M. L. S.; Johnstone, R. A. W. J. Chem. Soc.,
Perkin 2 1997, 489–494. Also describes the synthesis and
characterisation of compounds 3a–c used in this work.
12. Cristiano, M. L. S.; Johnstone, R. A. W.; Price, P. J. J.
Chem. Soc., Perkin 1 1996, 1453–1461.
22. 3,4-Dihydro-3-phenylpyrimidin-2(1H)-one 5a from 4a
(0.10 g; 0.49 mmol) irradiated in methanol (50 mL), 3 h.
The solvent was evaporated under reduced pressure at
room temperature to give 5a, 92% isolated yield. 1H NMR
(CDCl3): d 4.65–4.68 (2H, d), 5.25–5.50 (1H, m), 7.12–7.2
(1H, m), 7.37–7.43 (2H, m), 7.50–7.57 (2H, t), 10.35 (1H,
s); mmax.: 3212 (NH), 3054, 1693 (C@O), 1590, 1566, 1496,
1368, 1230, 1059, 756 cmꢀ1; MS (EI), m/z 175 [M+H]+.
23. 3,4-Dihydro-6-methyl-3-phenylpyrimidin-2(1H)-one
5b
from 4b, in methanol, irradiated 3.5 h, 97% isolated yield.
1H NMR (CDCl3): d 1.58–1.62 (2H, s), 3.75–3.78 (2H, d),
5.22–5.30 (1H, m), 6.15–6.25 (1H, m), 7.05–7.17 (2H, m),
7.25–7.42 (2H, m), 10.20 (1H, s); mmax.: 3284 (NH), 3085,
1681 (C@O), 1598, 1548, 1484, 1446, 1378, 1230, 1068,
755 cmꢀ1; MS (EI), m/z 189 [M+H]+; Acc. Mass (CI):
found = 189.10299, calcd for C11H13N2O: 189.10280.
24. 3,4-Dihydro-3,6-diphenylpyrimidin-2(1H)-one 5c from 4c,
13. Cristiano, M. L. S.; Johnstone, R. A. W. J. Chem. Res.,
(S) 1997, 164–165.
1
14. Arau´jo, N. C.; Barroca, P. M. M.; Brigas, A. F.; Cristiano,
M. L. S.; Jonhstone, R. A. W.; Loureiro, R. M. S.; Pena,
P. C. A. J. Chem. Soc., Perkin 1 2002, 9, 1213–1219.
15. Dunkin, I. R.; Shields, C. J.; Quast, H. Tetrahedron 1989,
45, 259–268.
in methanol, irradiated 5 h, 90% isolated yield. H NMR
(CDCl3): d 3.76–3.78 (2H, d), 5.42–5.48, (1H, m), 6.30–
6.45 (1H, m), 6.70–6.75 (1H, m), 6.85–7.05 (2H, m), 7.10–
7.35 (6H, m), 9.90 (1H, s); mmax.: 3220 (NH), 3066, 1701
(C@O), 1581, 1543, 1422, 1345, 1226, 1066, 756 cmꢀ1; MS
(EI), m/z 251 [M+H]+; Acc. mass (CI): found =
251.11809, calcd for C16H15N2O: 251.11844.
´
16. Gomez-Zavaglia, A.; Reva, I. D.; Frija, L.; Cristiano, M.
L.; Fausto, R. J. Phys. Chem. A, in press.
´
17. Gomez-Zavaglia, A.; Reva, I. D.; Frija, L.; Cristiano, M.
25. Stewart, J. J. P. J. Comp. Chem. 1989, 10, 221.
26. Stewart, J. J. P. MOPAC, A Semi-Empirical Molecular
Orbital Program. QCPE, 1983.
L.; Fausto, R. J. Mol. Spectroscopy, submitted for
publication.